approval · primary record
SODIUM GLYCEROPHOSPHATE
FDA · NDA · 2026-07-29
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-07-29 |
| Brand | GLYCOPHOS |
| Sponsor | FRESENIUS KABI USA |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:45.483Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:SODIUM GLYCEROPHOSPHATE:2026-07-29
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.